Clinical Trials Directory

Trials / Completed

CompletedNCT02941952

Comparative Noninvasive Continuous Cardiac Output by the Clearsight® With Invasive Monitoring by PICCO® in Abdominal Major Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In high-risk patients, it is now recommended to guide the intraoperative volume replacement via the stroke volume. Today, the most commonly used technique for estimating the stroke volume is the transpulmonary thermodilution and the arterial waveform analysis in the radial artery by PICCO®. This technique has the disadvantage of being invasive and increasing the time dedicated to anesthesia during the surgery. The future is the non-invasive monitoring of stroke volume. Thus, Edwards Life Science has developed a continuous monitoring technology and non-invasive arterial pressure, cardiac output and stroke volume using a digital sensor (ClearSight®). This continuous monitoring of blood pressure was validated in cardiothoracic surgery but studies about monitoring cardiac output or stroke volume are inconclusive and contradictory. The objective of this study is to compare the use of non-invasive monitoring of stroke volume by ClearSight® with the transpulmonary thermodilution and the arterial waveform analysis in radial artery by PICCO® in abdominal major surgery.

Conditions

Interventions

TypeNameDescription
DEVICECardiac output and stroke ejection volume monitoring with both ClearSight® and PICCO® in major abdominal surgery.

Timeline

Start date
2016-10-28
Primary completion
2018-05-07
Completion
2018-05-07
First posted
2016-10-21
Last updated
2018-05-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02941952. Inclusion in this directory is not an endorsement.